Growth Metrics

Boston Scientific (BSX) Current Deferred Tax Assets (2016 - 2019)

Boston Scientific (BSX) has disclosed Current Deferred Tax Assets for 11 consecutive years, with $195.0 million as the latest value for Q4 2019.

  • Quarterly Current Deferred Tax Assets rose 21.12% to $195.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $195.0 million through Dec 2019, up 21.12% year-over-year, with the annual reading at $195.0 million for FY2019, 21.12% up from the prior year.
  • Current Deferred Tax Assets hit $195.0 million in Q4 2019 for Boston Scientific, up from $189.0 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $496.0 million in Q4 2015 to a low of $43.0 million in Q3 2018.
  • Historically, Current Deferred Tax Assets has averaged $156.8 million across 5 years, with a median of $81.0 million in 2016.
  • Biggest five-year swings in Current Deferred Tax Assets: tumbled 84.88% in 2016 and later soared 339.53% in 2019.
  • Year by year, Current Deferred Tax Assets stood at $496.0 million in 2015, then crashed by 84.88% to $75.0 million in 2016, then fell by 12.0% to $66.0 million in 2017, then skyrocketed by 143.94% to $161.0 million in 2018, then rose by 21.12% to $195.0 million in 2019.
  • Business Quant data shows Current Deferred Tax Assets for BSX at $195.0 million in Q4 2019, $189.0 million in Q3 2019, and $175.0 million in Q2 2019.